Dr Somaiah on the Peak Trial in GIST

Neeta Somaiah, MD, discusses enrollment criteria for the phase 3 Peak trial in patients with gastrointestinal stromal tumor and the advantages of this trial’s design.

Related Keywords

Texas ,United States ,Neeta Somaiah ,Division Of Cancer Medicine ,University Of Texas Md Anderson Cancer Center ,Department Of Sarcoma Medical Oncology ,Sarcoma Medical Oncology ,Cancer Medicine ,Cancer Center ,D ,The University Of Texas Md Anderson Cancer Center ,Peak Trial ,Nct05208047 ,Patients With Gastrointestinal Stromal Tumor ,